Project Grant R41HL176259
Award Date
9/20/24
Completion Date
9/19/25
Dollars Obligated
$307K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Mira Medical, LLC (ZB3HTDBZKE67)
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Potomac, MD 20854, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), focuses on developing and demonstrating a high-volume manufacturing technology for microfluidic oxygenators. The goal is to enable safer, simpler treatment of respiratory failure through extracorporeal membrane oxygenation (ECMO) therapy. The $294,063 award to Biomembretics, Inc. will fund a two-phase project to: 1) define the target...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $870,467 to Ension Inc. to develop an innovative bearingless (magnetically levitated) flux reversal motor for a pediatric cardiopulmonary assist system (PCAS). The goal is to extend the operating range of this novel motor design to accommodate the high pressure and low flow requirements for neonatal and infant patients weighing 5-15 kg....
This $163,760 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research at Tufts Medical Center to investigate how the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) impacts ventricular-arterial coupling and myocardial injury in patients with acute myocardial infarction and cardiogenic shock. The 5-year project aims to 1) determine how VA-ECMO alters...
The federal Project Grant award R41HL176279 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The $423,921 award supports the development of an innovative, single-operator pneumothorax decompression device to improve the safety and efficiency of therapeutic decompression procedures for neonatal patients. The awardee, Advanced Medical Electronics Corp (A M E C), a for-profit medical technology company in Maple...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $676,970 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Geisinger Clinic in Danville, Pennsylvania. The project will investigate the in vivo effects of non-pulsatile versus pulsatile blood flow with the BiVACOR total artificial heart on blood trauma, arterial remodeling, and vasoregulation in a chronic bovine model. The goal is to provide insight into the pathophysiologic mechanisms of adverse...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,564,220 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Trustees of the University of Pennsylvania to develop an imaging-compatible ex vivo lung perfusion (EVLP) system. The goal is to obtain structural, functional, and metabolic biomarkers that can be used to optimize EVLP parameters and assess the reconditioning of donor lungs with common defects, such as atelectasis, ventilator-induced...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,160,157 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Liberandum Technologies, Inc. in San Francisco, CA. The goal of this Phase I Small Business Innovation Research (SBIR) project is to develop and test a bidirectional synchronous flow-controlled ventilation system to improve oxygenation and ventilation in patients with acute respiratory distress syndrome (ARDS). The ventilation system aims to provide gentle...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,924 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Convergent Engineering, Inc. to develop a prototype decision support system for personalizing mechanical ventilation care. The proposed system aims to simplify the use of esophageal pressure measurements and provide decision support to optimize ventilator settings and prevent complications for ventilated patients. Key objectives include...
This Project Grant award for $117,750.00 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to Ann & Robert H. Lurie Children's Hospital of Chicago. The funding will support research to validate the use of wireless biosensors and a portable capnograph as an alternative to hand-collected vital sign data for remote monitoring of pediatric patients on home mechanical ventilation. The project also aims to...